Insight on Pharmaceuticals

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Results are sorted by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Company Analysis: Johnson & Johnson

Analysis of Johnson & Johnson's corporate strategy, marketed portfolio, pipeline potential, and financial position in 2011 and to 2017.

Published By Datamonitor
17 Dec 2012 $2800
Buy
Report
Report

Pharmaceutical Diversification Trends 2012

This report compares the main diversification strategies used by pharma companies, in addition to the merger, acquisition, and divestment history of the top 10 companies, which have been instrumental in shaping the industry’s current business model.

Published By Datamonitor
20 Jun 2012 $2800
Buy
Report
Report

Mexico: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
07 Jul 2011 $1520
Buy
Report
Report

Sanofi: PharmaVitae Report

Analysis of Sanofi corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and 2016

Published By Datamonitor
24 Jun 2011 $2800
Buy
Report
Report

Spain Pharmaceutical Market Overview – Continued stagnation as generics and price cuts erode market value

Overview of the pharmaceutical market in Spain including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis, and pharmaceutical market and pharmaceutical company infrastructure analysis.

Published By Datamonitor
11 Oct 2012 $2800
Buy
Report
Report

Brazil Pharmaceutical Market Overview – Strong market growth continues, but regulatory risks increase

Overview of the pharmaceutical market in Brazil including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis, and pharmaceutical market and pharmaceutical company infrastructure analysis.

Published By Datamonitor
21 Sep 2012 $2800
Buy
Report
Report

Teva Pharma. Industries Ltd: PharmaVitae Generics Report

Analysis of Teva's corporate strategy and sales performance in 2010 to 2016.

Published By Datamonitor
04 May 2012 $2800
Buy
Report
Report

Dendreon Corporation: PharmaVitae Report

This report analyzes Dendreon's corporate strategy and sales outlook through to 2016, supported by in-depth analysis of the company’s key products and pipeline, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
27 Jan 2012 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview

Analysis of socio-demographic and economic trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
13 Apr 2011 $1520
Buy
Report
Report

France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth

Overview of the French pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
17 Dec 2010 $3600
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.